ENVB

NASDAQ · Pharmaceuticals

Enveric Biosciences Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$1.55

-0.12 (-7.19%)

As of Aug 8, 2:36 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +539.4% upside

Low Target $5.56

Average Target $9.91

High Target $13.09

Current Price $1.55

Current
$1.55

Target
$9.91

$5.56 $9.91 avg $13.09

Scenario Analysis

Bear Case

$5.56

258.7%

Low target

Base Case

$9.91

+539.4%

Avg target

Bull Case

$13.09

+744.5%

High target

Risk/Reward

2.9x

Favorable

Price in Context

52-Week High

$17.64

-91.2% from high

52-Week Low

$1.25

+24.0% from low

Target vs 52W High

$9.91

-43.8% vs high

Next Earnings Report

Aug 12, 2026

until earnings

Earnings in 2 days. Analyst targets may shift significantly after the report.

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%